US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

Thiamine Hydrochloride 200 mg/2mL

Reason Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.

McGuff Compounding Pharmacy Services, Inc. D-0266-2023
Class II · Moderate risk Terminated

Quinapril Tablets USP

Reason CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Lupin Pharmaceuticals Inc. NDC 68180-558-09 D-0089-2023
Class II · Moderate risk Terminated

Quinapril Tablets USP

Reason CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

Lupin Pharmaceuticals Inc. NDC 68180-554-09 D-0088-2023
Class II · Moderate risk Terminated

Desmopressin Acetate Tablet

Reason Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.

RemedyRepack Inc. D-0077-2023
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0079-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0078-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0077-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0076-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0075-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0074-2024
Class II · Moderate risk Completed

TUMS Antacid

Reason Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.

GlaxoSmithKline Consumer Healthcare Holdings LLC D-0073-2024
Class II · Moderate risk Terminated

Oxcarbazepine Tablets 600mg

Reason Presence of foreign substance

Sun Pharmaceutical Industries INC NDC 62756-185-88 D-0085-2023
Class II · Moderate risk Terminated

FentaNYL Citrate 2.5 mg/50 mL

Reason Underfilled units.

OurPharma LLC NDC 73013-001-01 D-0078-2023
Class II · Moderate risk Terminated

Sensorcaine-MPF

Reason Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Fresenius Kabi USA, LLC NDC 63323-468-01 D-0129-2023
Class II · Moderate risk Terminated

Sensorcaine

Reason Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Fresenius Kabi USA, LLC NDC 63323-463-01 D-0128-2023
Class II · Moderate risk Terminated

Sensorcaine

Reason Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.

Fresenius Kabi USA, LLC NDC 63323-461-01 D-0127-2023
Class II · Moderate risk Ongoing

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility: Leakage of 0.9% Sodium Chloride for Injection, 1L, 12pk Saline Solution.

Fresenius Medical Care Holdings, Inc. NDC 49230-300-10 D-0075-2023
Class II · Moderate risk Ongoing

Daytrana

Reason Defective Delivery System: Recalled lot was found to be out of specification for shear. Shear is an attribute related to the adhesive properties of the transdermal patches.

Noven Pharmaceuticals Inc NDC 68968-5553-3 D-0071-2023
Class II · Moderate risk Terminated

PF-Neostigmine Methylsulfate Injection

Reason CGMP Deviations: Potential for cross contamination due to product carry over.

Nephron Sterile Compounding Center LLC NDC 69374-932-33 D-0065-2023
Class II · Moderate risk Terminated

PF-Labetalol HCl Injection

Reason CGMP Deviations: Potential for cross contamination due to product carry over.

Nephron Sterile Compounding Center LLC NDC 69374-946-34 D-0064-2023
Class II · Moderate risk Terminated

Phenoxybenzamine Hydrochloride Capsules

Reason Failed Impurities/Degradation Specifications

Par Formulations Private Limited NDC 49884-038-01 D-0061-2023
Class II · Moderate risk Ongoing

0.9% Sodium Chloride Injection

Reason Lack of assurance of sterility: Bags have the potential to leak in the flexible containers which may compromise sterility.

ICU Medical Inc NDC 0990-7984-37 D-0062-2023